Pevaryl en es it fr

Pevaryl Brand names, Pevaryl Analogs

Pevaryl Brand Names Mixture

  • No information avaliable

Pevaryl Chemical_Formula


Pevaryl RX_link

Pevaryl fda sheet

Pevaryl FDA

Pevaryl msds (material safety sheet)

Pevaryl Synthesis Reference

No information avaliable

Pevaryl Molecular Weight

277.279 g/mol

Pevaryl Melting Point

No information avaliable

Pevaryl H2O Solubility

Slightly soluble (2.4 mg/mL at pH 7.9, 25oC)

Pevaryl State


Pevaryl LogP

No information avaliable

Pevaryl Dosage Forms

Film-coated tablets for oral administration (0.5 mg, 1 mg); Oral solution (0.05 mg/mL)

Pevaryl Indication

For the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

Pevaryl Pharmacology

Entecavir is a guanosine nucleoside analogue with selective activity against hepatitis B virus (HBV). It is designed to selectively inhibit the Hepatitis B virus, blocking all three steps in the replication process. Entecavir is more efficient than an older Hepatitis B drug, lamivudine.

Pevaryl Absorption

Absorption Following oral administration in healthy subjects, entecavir peak plasma concentrations occurred between 0.5 and 1.5 hours. In healthy subjects, the bioavailability of the tablet is 100% relative to the oral solution.

Pevaryl side effects and Toxicity

No information avaliable

Pevaryl Patient Information

Pevaryl Organisms Affected

Hepatitis B